Stockreport

CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec

CG Oncology, Inc.  (CGON) 
PDF IRVINE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercia [Read more]